Marcin Ludwik Leja

Mr. Marcin Ludwik Leja

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
Konrad Andrzej SzychowskiKonrad Andrzej Szychowski
Konrad Andrzej Szychowski
MLMarcin Ludwik Leja
Marcin Ludwik Leja
DKDanylo Kaminskyy
Danylo Kaminskyy
UBUrszula E. Binduga
Urszula E. Binduga
OPOleh R. Pinyazhko
Oleh R. Pinyazhko
JGJan Gmiński
Jan Gmiński

15 March 2016 in Environmental Science and Pollution Research
Verified
Journal Article
Open access
PDF file
Konrad Andrzej SzychowskiKonrad Andrzej Szychowski
Konrad Andrzej Szychowski
KRKamila Rybczyńska-Tkaczyk
Kamila Rybczyńska-Tkaczyk
MLMarcin Ludwik Leja
Marcin Ludwik Leja
AWAnna Katarzyna Wójtowicz
Anna Katarzyna Wójtowicz
JGJan Gmiński
Jan Gmiński
Tetrabromobisphenol A (TBBPA) is a widely used brominated flame retardant, applied in a variety of commercial and household products, mainly electronic ones. Since the production of reactive oxygen species (ROS) is considered one of the principal cytotoxicity mechanisms, numerous studies undertake that aspect of TBBPA’s mechanism of action. The present study verifies if the fluorogenic substrate 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) should be used to detect ROS production induced by TBBPA. To determine the ability of TBBPA alone to stimulate the conversion of H2DCFDA to its fluorescent product 2’,7’-dichlorofluorescein (DCF), we used a cell-free model. In the experiments we check different cultured media also in combination with free radical scavenger N-acetyl-l-cysteine (NAC). Additionally, experiments with stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH·) have been made. The presented data showed that TBBPA in all tested concentrations interacts with H2DCFDA in phosphate-buffered saline (PBS) buffer while in micromolar concentrations in the DMEM/F12 medium with and without serum. The addition of NAC inhibited the interaction of TBBPA with H2DCFDA. Experiments with DPPH· showed that, in the presence of NAC, TBBPA acts like a free radical. TBBPA has similar properties to free radical and is susceptible to free radical scavenging properties of NAC. Our results indicated that H2DCFDA assay cannot be used to evaluate cellular ROS production in TBBPA studies. The study connected with TBBPA-stimulated ROS production in cell culture models using the H2DCFDA assay should be revised using a different method. However, due to the free radical-like nature of TBBPA, it can be very difficult. Therefore, further investigation of the nature of TBBPA as a compound with similar properties to free radical is required.

1 December 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Konrad Andrzej SzychowskiKonrad Andrzej Szychowski
Konrad Andrzej Szychowski
MLMarcin Ludwik Leja
Marcin Ludwik Leja
DKDanylo V. Kaminskyy
Danylo V. Kaminskyy
AKAnna P. Kryshchyshyn-Dylevych
Anna P. Kryshchyshyn-Dylevych
UBUrszula E. Binduga
Urszula E. Binduga
JGJan Gmiński
Jan Gmiński

1 December 2018 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
Konrad Andrzej SzychowskiKonrad Andrzej Szychowski
Konrad Andrzej Szychowski
UBUrszula E. Binduga
Urszula E. Binduga
KRKamila Rybczyńska-Tkaczyk
Kamila Rybczyńska-Tkaczyk
MLMarcin Ludwik Leja
Marcin Ludwik Leja
JGJan Gmiński
Jan Gmiński
Garlic (Allium sativum L., Alliaceae) has acquired a reputation as a therapeutic agent and herbal remedy to prevent and treat several pathologies. The aim of the present study was to determine the effect of two Allium sativum L. cultivars, Harnaś and Morado, on reactive oxygen species (ROS) production, viability and apoptotic process in human squamous carcinoma cell line SCC-15. The experiments were conducted on SCC-15 cell line exposed to increasing concentrations of garlic extracts of 0.062, 0.125, 0.250, 0.500 and 1.000 mg/mL. After the experiments, ROS formation, caspase-3 activity and neutral red uptake were measured in the cells, and in a collected medium lactate dehydrogenase (LDH) release was measured. The Spanish cultivar Morado has demonstrated higher potential to stimulate ROS production in SCC-15 cells after a short time period (6 h) than the Polish cultivar Harnaś. However, the Polish cultivar Harnaś manifested more prolonged potential to stimulate ROS production in SCC-15 cells. Both studied garlic extracts induced cytotoxicity on SCC-15 cell line which was probably ROS-dependent. We also determined that in SCC-15 cells high concentrations of studied extracts did not cause activation of caspase-3 which suggested caspase-independent or necrotic cell death.

23 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Konrad Andrzej SzychowskiKonrad Andrzej Szychowski
Konrad Andrzej Szychowski
DKDanylo V. Kaminskyy
Danylo V. Kaminskyy
MLMarcin Ludwik Leja
Marcin Ludwik Leja
AKAnna P. Kryshchyshyn-Dylevych
Anna P. Kryshchyshyn-Dylevych
Roman LesykRoman Lesyk
Roman Lesyk
JGJan Gmiński
Jan Gmiński
4-thiazolidinones, which are privileged structures in medicinal chemistry, comprise the well-known class of heterocycles and are a source of new drug-like compounds. Undoubtedly, the 5-bulky-substituted-2,4-thiazolidinediones - a class of antihyperglycemic glitazones, which are peroxisome proliferator-activated receptor gamma (PPARγ) agonists, are the most described group among them. As there are various chemically distinct 4-thiazolidinones, different subtypes have been selected for studies; however, their main pharmacological profiles are similar. The aim of this study was to evaluate the anticancer activity of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one (Les-236) in four human cancer cell lines, A549, SCC-15, SH-SY5Y, and CACO-2, and investigate its impact on the production of reactive oxygen species (ROS) and the apoptotic process as well as cytotoxicity and metabolism in these cell lines. The cell lines were exposed to increasing concentrations (1 nM to 100 µM) of the studied compound for 6, 24, and 48 h, and later, ROS production, cell viability, caspase-3 activity, and cell metabolism were examined. The obtained results showed that the studied compound decreased the production of ROS, increased the release of lactate dehydrogenase, and decreased cell metabolism/proliferation in all the five cell lines at micromolar concentrations. Interestingly, over a wide range of concentrations (from 1 nM to 100 µM), Les-236 was able to increase the activity of caspase-3 in BJ (after 6 h of exposure), A549, CACO-2, and SCC-15 (after 48 h of exposure) cell lines which could be an effect of the activation of PPARγ-dependent pathways.

28 January 2023 in Genes
Verified
Journal Article
Open access
PDF file
NBNatalia Bałdyga
Natalia Bałdyga
DODominika Oziębło
Dominika Oziębło
NGNina Sara Gan
Nina Sara Gan
MFMariusz Furmanek
Mariusz Furmanek
MLMarcin Ludwik Leja
Marcin Ludwik Leja
MOMonika Oldak
Monika Oldak
The most frequently observed congenital inner ear malformation is enlarged vestibular aqueduct (EVA). It is often accompanied with incomplete partition type 2 (IP2) of the cochlea and a dilated vestibule, which together constitute Mondini malformation. Pathogenic SLC26A4 variants are considered the major cause of inner ear malformation but the genetics still needs clarification. The aim of this study was to identify the cause of EVA in patients with hearing loss (HL). Genomic DNA was isolated from HL patients with radiologically confirmed bilateral EVA (n = 23) and analyzed by next generation sequencing using a custom HL gene panel encompassing 237 HL-related genes or a clinical exome. The presence and segregation of selected variants and the CEVA haplotype (in the 5′ region of SLC26A4) was verified by Sanger sequencing. Minigene assay was used to evaluate the impact of novel synonymous variant on splicing. Genetic testing identified the cause of EVA in 17/23 individuals (74%). Two pathogenic variants in the SLC26A4 gene were identified as the cause of EVA in 8 of them (35%), and a CEVA haplotype was regarded as the cause of EVA in 6 of 7 patients (86%) who carried only one SLC26A4 genetic variant. In two individuals with a phenotype matching branchio-oto-renal (BOR) spectrum disorder, cochlear hypoplasia resulted from EYA1 pathogenic variants. In one patient, a novel variant in CHD7 was detected. Our study shows that SLC26A4, together with the CEVA haplotype, accounts for more than half of EVA cases. Syndromic forms of HL should also be considered in patients with EVA. We conclude that to better understand inner ear development and the pathogenesis of its malformations, there is a need to look for pathogenic variants in noncoding regions of known HL genes or to link them with novel candidate HL genes.